Dec 15 (Reuters) - Abbvie Inc ABBV.N :
* HEALTH CANADA APPROVES VENCLEXTA® (VENETOCLAX) IN COMBINATION WITH AZACITIDINE OR LOW DOSE CYTARABINE FOR UNTREATED ACUTE MYELOID LEUKEMIA (AML)
* HEALTH CANADA APPROVES VENCLEXTA (VENETOCLAX) IN COMBINATION WITH AZACITIDINE OR LOW DOSE CYTARABINE FOR UNTREATED ACUTE MYELOID LEUKEMIA (AML)